• FDA Public Webinar: Genome Editing in Animals

    Online

    On December 3, 2018, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM), with participation from the FDA’s Center for Biologics Evaluation and Research (CBER), will hold a public webinar about genome editing in animals. Genome editing is an innovative and rapidly evolving technology that offers many promising benefits to both human and

  • Fighting Ebola in DRC: New Tools and New Challenges

    Webinar

    Join Doctors Without Borders for a live webcast panel discussion on January 29 from 12:30 PM – 2:00 PM EST on efforts to contain the current Ebola epidemic in Democratic Republic of Congo (DRC). MSF teams are responding to the second largest Ebola outbreak ever recorded, trying to halt the spread of this highly infectious,

  • National Toxicology Program Peer-Review Meeting on Effects of Sarin Exposure

    Webinar

    The National Toxicology Program will host a public webinar on 4 Feb 2019 to discuss the draft findings of a systematic review to evaluate the evidence for long-term neurological effects in humans and animals following acute exposure to sarin. Sarin is a highly toxic organophosphorus nerve agent that was developed for chemical warfare during World War II

  • Fighting the Next War: Defense Against Biological Weapons

    Council on Foreign Relations 1777 F Street, NW, Washington, DC, United States

    The Blue Ribbon Study Panel on Biodefense will host an in-depth discussion on the role of the U.S. Defense Department in biodefense on February 5th, 2019 in Washington, DC. Participants will share their experiences regarding the current threat environment, research and development programs, and the Department's biodefense policies. RSVP by January 30, 2019. Attendance is

  • Mass Drug Administration and Antimicrobial Resistance

    John Snow Lecture Theatre - LSHTM Keppel Street, London, United Kingdom

    The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London, UK and by live stream. Mass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium

  • Vaccine Strategies for Endemic Fungal Pathogens

    Webinar

    The National Institute of Allergy and Infectious Diseases (NIAID) will host a Vaccine Strategies for Endemic Fungal Pathogens meeting on 5-6 March 2019 to discuss the scope of endemic fungal disease, learn about the latest discoveries, and determine actionable steps to advance fungal vaccines. This meeting will take place at the NIAID Conference Center in

  • Long-Term Health Monitoring following Nuclear & Radiological Emergencies

    Keck Center 500 5th Street Northwest, Washington, DC, United States

    The National Academies’ Nuclear and Radiation Studies Board (NRSB) will host “Challenges in Initiating and Conducting Long-Term Health Monitoring of Populations following Nuclear and Radiological Emergencies in the United States: A Workshop” on 12-13 March 2019 in Washington, D.C. Workshop participants will discuss the following topics: Environmental Consequences of Radioactive Material following a Nuclear or

  • Planning Webinar: Tools and Resources for Upcoming National Infant Immunization Week

    Webinar

    Join the Centers for Disease Control and Prevention (CDC) for a planning webinar on 12 March 2019 to learn about National Infant Immunization Week planning tools, digital communication resources, and how to get involved with CDC activities planned for the week. This year marks the 25th anniversary of National Infant Immunization Week (NIIW). From April

  • Biosafety Concerns of Cell Sorting: Policies, Procedures, and PPE

    Hood College Coblentz Hall 650 Blazer Trail, Frederick, MD, United States

    The ChABSA will host a technical seminar by Drs. Kristen Reifel and Brandon Swan on the biosafety concerns involved in cell sorting on March 12, 2019 in Frederick, Md. Remote participation is available via webcast. Dr. Kristen M. Reifel is a Principal Investigator in the Genomics group at the National Biodefense Analysis and Countermeasures Center